182.51
price up icon2.48%   4.41
after-market Dopo l'orario di chiusura: 182.29 -0.22 -0.12%
loading

Krystal Biotech Inc Azioni (KRYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.37%
45.25
42.14 8.556 - -
Operating Expenses
33.15%
51.93
39.01 34.55 38.05 48.82
Benefits Costs and Expenses
100.00%
-
37.80 - - -
Costs And Expenses
162.11%
51.93
-83.62 34.55 - -
Operating Income/Loss
313.00%
-6.684
3.138 -25.99 -38.05 -48.82
Income/Loss From Continuing Operations Before Tax
942.39%
45.25
4.341 8.556 -33.21 -45.30
Income/Loss From Continuing Operations After Tax
89.28%
0.932
8.692 80.75 -33.21 -45.30
Net Income/Loss
89.28%
0.932
8.692 80.75 -33.21 -45.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,176%
28.30
0.3419 28.04 26.66 25.71
Diluted Average Shares
7,875%
29.29
0.3673 28.89 26.66 25.71
Basic Earnings Per Share
90.63%
0.03
0.32 2.88 -1.25 -1.76
Diluted Earnings Per Share
90.32%
0.03
0.31 2.79 -1.25 -1.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):